Clinical Trials Directory

Trials / Unknown

UnknownNCT02434978

Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
125 (estimated)
Sponsor
Odense University Hospital · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The present study is a randomized controlled trial (RCT) that examines if the outcome of peptic ulcer bleeding could be improved by use of doppler-guided endoscopic treatment.

Detailed description

This study evaluates if performance of a control endoscopy with doppler-guided endoscopic treatment is associated with an improved outcome in term of lower rate of rebleeding and lower rate of bleeding-related mortality. A potential risk of increased risk of complications (in particular perforation) among patients treated with control endoscopy is also evaluated. Outcomes are prospectively registered based on patient records.

Conditions

Interventions

TypeNameDescription
DEVICESupplementary endoscopy with doppler-guided therapyPatients randomized to supplementary doppler-guided therapy undergo repeat endoscopy with doppler evaluation within 24 hours from the primary endoscopy. At the control endoscopy the ulcer base is examined using a doppler device. If active doppler flow is demonstrated the ulcer is treated with a thermal probe until a control doppler-scan is negative. All patients are observed for rebleeding at a specialized GI-bleeding unit.
DRUGIV. PPIAll patients receive 80mg of Esomeprazole iv as a bolus followed by 8mg Esomeprazole per hour for 72 hours.
OTHEREndoscopic treatment at primary endoscopyAll patients are initially treated with endoscopic therapy using a minimum of two different treatment modalities. The primary endoscopy is performed wihtin 24 hours from time of admission to hospital

Timeline

Start date
2014-01-01
Primary completion
2017-09-01
Completion
2018-03-01
First posted
2015-05-06
Last updated
2017-04-20

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02434978. Inclusion in this directory is not an endorsement.